Audax Medical, Inc. Licenses Nanomolecule Technology from Northeastern University for COVID-19 Anti-Viral Therapy
CONCORD, Mass., April 23, 2020 /PRNewswire/ — Audax Medical, Inc. has secured an exclusive worldwide license from Northeastern University for an advanced nanomolecular technology addressing the development of COVID-19 and other anti-viral therapies. In collaboration with Dr. Thomas Webster, Art Zafiropoulo Chair and Professor of Chemical Engineering at Northeastern University, the company adds to their existing … Read more